brand logo

Am Fam Physician. 2022;106(5):485

Author disclosure: No relevant financial relationships.

To the Editor: I appreciated the excellent review of chlamydia and gonorrhea infections provided by Dr. Yonke and colleagues.1 Doxycycline is now the preferred treatment for chlamydia, with azithromycin as an alternative.2

The authors are correct that this change was partially based on increasing rates of macrolide resistance. However, it is important that family physicians know that there are additional reasons for the recommendation change, which can help them adequately counsel patients and ensure appropriate follow-up.

Doxycycline is a more effective treatment for rectal chlamydia than azithromycin. In a study of rectal chlamydia in men who have sex with men, 100% of patients treated with doxycycline achieved microbiologic cure vs. 74% of those treated with azithromycin.3 In another study, 95.5% of women with rectal chlamydia treated with doxycycline achieved a microbiologic cure, compared with 78.5% of women treated with azithromycin.4 This difference is significant because many women with urogenital chlamydia may have a concurrent rectal infection. One recent review found that 33% to 83% of women with urogenital chlamydia also had a rectal infection, regardless of reported receptive anal intercourse.5 Patients may receive insufficient treatment for chlamydia if treated with azithromycin alone.

Editor's Note: This letter was sent to the authors of “Chlamydial and Gonococcal Infections: Screening, Diagnosis, and Treatment,” who declined to reply.

Email letter submissions to Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading

More in AFP

More in PubMed

Copyright © 2022 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.